<DOC>
	<DOCNO>NCT02910817</DOCNO>
	<brief_summary>quasi-experimental study investigate whether metformin co-treatment would improve IVF outcome overweight obese woman PCOS .</brief_summary>
	<brief_title>Impact Metformin In Vitro Fertilization Outcomes Overweight Obese PCOS Women</brief_title>
	<detailed_description>This non randomized prospective control `` metformin-free group '' study take place University IVF Center . The study include fifty-one overweight obese woman ( BMI &gt; 25 ) PCOS underwent first fresh autologous IVF-embryo transfer cycle agree take metformin IVF cycle `` Metformin-treated group '' . A cross match cohort fifty-one cross match PCOS woman agree take study medication allocate control group `` Metformin-free group '' . The metformin-treated group receive metformin ( 1000 mg per day ) start control ovarian stimulation ( COH ) day pregnancy check . The primary outcome measure total number retrieve oocyte live birth rate .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>The inclusion criterion restrict patient 39 year old basal FSH &lt; 10 IU/ml normal TSH prolacin . Exclusion criterion diabetes mellitus ( excluded GTT ) , renal liver disease , associate male factor , document tubal factor pelvic adhesion , elevate 17 alfa hydroxyprogesterone level FSH â‰¥10 IU/ml . We also exclude woman start program medication reduce weight partner abnormal semen parameter accord world health organization parameter ( WHO , 2010 )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>